Gilde Healthcare has invested in Tandarts Today
Gilde Healthcare has invested in Tandarts Today, a fast-growing dental chain in the Netherlands. The investment will allow Tandarts Today to accelerate its buy-and-build strategy and become a leading dental chain in the Netherlands. Financial details have not been disclosed.
Tandarts Today, founded in 2015, offers all disciplines of regular dentistry, including special treatments such as implantology, orthodontics, periodontology and aesthetic treatments. Furthermore, through its own dental laboratories, it develops hockey bits, custom-made prostheses, bridges and other dental work pieces.
Gilde Healthcare is a specialized European healthcare investor managing over US$1.5 billion across two fund strategies: venture & growth capital and private equity. Gilde Healthcare’s venture & growth capital fund invests in health tech and therapeutics. The venture & growth companies are based in Europe and North America. Gilde Healthcare’s private equity fund invests in profitable European lower mid-market healthcare companies, with a focus on the Benelux and DACH regions. The private equity fund targets healthcare, suppliers of medical products and service providers in the healthcare market.
Oaklins’ team in the Netherlands acted as the exclusive financial advisor to the seller in this transaction.
Ruben Hoefnagels
Founder and CEO, Tandarts Today
Sprechen Sie mit dem Deal-Team
Sander van 't Spijker
Oaklins Netherlands
Transaktionen
Bolster Investment Partners hat eine Mehrheitsbeteiligung an Eternal Sun erworben
Bolster Investment Partners, eine in den Niederlanden ansässige Investmentfirma, hat eine Mehrheitsbeteiligung an Eternal Sun, einem weltweit führenden Technologieunternehmen für hochentwickelte Solarmodul-Testsysteme, von ABN AMRO Sustainable Impact Fund, einem privaten Impact Fund mit Sitz in den Niederlanden, und Vermec, einer in Belgien ansässigen Investmentfirma, erworben.
Mehr erfahrenCerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Mehr erfahreniwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Mehr erfahren